Simple Blood Test May Predict Mortality Risks in Elderly Kidney Patients

A new study has highlighted a simple blood marker that could help predict health risks in older adults with chronic kidney disease (CKD). Researchers found that the monocyte-to-HDL ratio (MHR) is strongly linked to higher mortality rates in this group. The findings suggest that tracking MHR may improve how clinicians manage inflammation and related complications in elderly CKD patients.

The study, published in the Journal of Translational Medicine, was led by a team including Gembillo, Soraci, and Luciani. They analysed data from 1,248 elderly CKD patients treated at nephrology clinics across Sicily, Italy. Their research revealed that those with elevated MHR levels faced significantly worse health outcomes, including higher overall and kidney-related mortality.

MHR measures the balance between monocytes—a type of white blood cell—and HDL cholesterol, often called 'good' cholesterol. A high ratio signals increased inflammation, which can worsen existing health problems in older adults with CKD. The study emphasised that lifestyle changes, such as better diets and regular exercise, could help lower MHR and reduce risks.

The findings also pointed to broader clinical applications. By routinely monitoring MHR, doctors might spot early signs of inflammation and act faster to prevent complications. This approach could lead to more personalised care for elderly CKD patients, focusing on both medical and lifestyle interventions.

The research underscores MHR's potential as a key tool in geriatric medicine, particularly for those with CKD. Further studies are still needed to confirm its role in everyday clinical practice and explore effective ways to lower MHR. For now, the results offer a clearer path for managing inflammation in older adults with kidney disease.